Successful in vivo results
Redbiotec is pleased to announce that it has further validated [...]
Redbiotec selected by University of Alabama for hCMV immuno-correlation study
Redbiotec and the research group of Prof. William J. Britt, [...]
Publication CMV patent application
Redbiotec is pleased to announce the publication of the patent [...]
Further international support for Redbiotec
Redbiotec announces today the appointment of Prof. Monique van Oers [...]
Invitation by Swiss Economic Forum
Redbiotec CEO Christian Schaub has been invited to an exclusive [...]
Positive PCT report for Redbiotec’s CMV patent application
Redbiotec is pleased to announce that the international search report [...]
Collaboration with GSK Vaccines
Redbiotec is pleased to announce that is has entered into [...]
EU grant for Redbiotec
Redbiotec is one of the partners who were granted the [...]
Redbiotec and TeselaGen to partner on Herpesvirus vaccine library
San Francisco, CA, and Zurich, Switzerland. Redbiotec and TeselaGen have [...]
Further international support for Redbiotec in Herpesvirus/CMV field
Redbiotec AG announces today the appointment of Prof. Dr. Bodo [...]